Clinipace Blog

Clinipace Expert to Speak at the ACRP 2015 Global Conference

Our very own Clinical Trials Manager, Deborah Rosenfelder, will share her expertise at the ACRP 2015 Global Conference this Saturday, April 25th, in Salt Lake City, Utah. She will be speaking on the panel, “Walk the Talk: Implementing Risk-Based Monitoring,” with... read more

Clinipace Acquires Germany-Based Accovian

We’re pleased to announce the closing of our merger with Accovion, a leading European full-service CRO headquartered in Frankfurt (Eschborn), Germany. Bringing these organizations together strengthens our operational and therapeutic expertise in Europe, with strong... read more

New eBook: Cancer Drug Development Using Molecular Pathology

Considerable resources are expended for the prevention and treatment of cancer. In fact, it’s the second most common cause of death in the United States, and accounts for $216.6 billion in costs annually. However, most drugs are prescribed based on histology and not... read more

Clinipace Attending CED 2015 Life Science Conference

Clinipace will be attending the CED Life Science Conference, the leading life science conference in the Southeast, March 3-4 in Raleigh, NC. Keep an eye out for our team members, including CEO Jeff Williams and Darcy Forman, senior director of project management.... read more

Clinipace Announces $50 Million M&A War Chest

We are thrilled to announce our company has closed a $50 million round of debt and equity financing to capitalize on a pipeline of corporate acquisitions. The financing was led by Virgo Investment Group, LLC (“Virgo”) of Redwood Shores, CA, and its investor partners,... read more
Share This